Connect Sign In
LabMind podcasts
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in December. |
January 4, 2023 |
ARUP Consult Provides New Resources on Multiple Sclerosis, Minimal Residual Disease, and Mumps Virus ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated educational resources for multiple sclerosis, minimal residual disease, and mumps virus. |
|
December 21, 2022 |
New ARUP Resource Simplifies Laboratory Testing Decisions for Clinicians Treating Multiple Sclerosis A new ARUP Consult tool helps clarify the testing requirements for medication management when clinicians are treating patients with multiple sclerosis. |
Jennifer (Jenna) Rychert, PhD, ARUP medical director of Operational Informatics and Microbial Immunology, and Jonathan Genzen, MD, PhD, ARUP chief medical officer, coauthored the report of the new study, “Laboratory-Developed Test Orders in an Academic Health System.” |
December 15, 2022 | Laboratory-developed tests made up only about 4% of an academic health system’s total test orders in 2021, yet they played an important role in patient care, a new study shows. |
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in November. |
December 6, 2022 |
ARUP Consult Updates Resources on Venous Thromboembolism, Cytomegalovirus, and Hemoglobinopathies ARUP Consult, a free source of expert guidance in laboratory testing, has updated educational resources for venous thromboembolism, cytomegalovirus, and hemoglobinopathies. |
|
December 1, 2022 |
ARUP Honored With Utah Business Magazine’s Best Companies To Work For Award ARUP’s culture of caring has earned it Utah Business magazine’s Best Companies To Work For Award for a fifth consecutive year. |
The condition of venous thromboembolism, illustrated here, can be treated using direct oral anticoagulants (DOACs) such as direct factor Xa inhibitors. ARUP’s new chromogenic assays can be used to help assess treatment efficacy. |
November 28, 2022 |
New ARUP Tests Measure Levels of Direct Factor Xa Inhibitors to Ensure Quality Patient Care Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the efficacy and safety of this treatment can be measured with ARUP’s newest test offerings. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat